Extended-release venlafaxine in relapse prevention for patients with major depressive disorder
- 30 June 2004
- journal article
- clinical trial
- Published by Elsevier in Journal of Psychiatric Research
- Vol. 38 (3) , 249-257
- https://doi.org/10.1016/j.jpsychires.2003.10.004
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic reviewThe Lancet, 2003
- Low Serum Cholesterol Concentration and Risk of SuicideEpidemiology, 2001
- Antidepressants in long‐term therapy: a review of tricyclic antidepressants and selective serotonin reuptake inhibitorsActa Psychiatrica Scandinavica, 2000
- Double-blind, placebo-substitution study of nefazodone in the prevention of relapse during continuation treatment of outpatients with major depressionInternational Clinical Psychopharmacology, 1999
- Efficacy of once-daily venlafaxine extended release (XR) for symptoms of anxiety in depressed outpatientsJournal of Affective Disorders, 1998
- An Open-Label Evaluation of the Long-Term Safety of Oral Venlafaxine in Depressed Elderly PatientsAnnals of Clinical Psychiatry, 1996
- Methodologic Issues in Maintenance Therapy Clinical TrialsArchives of General Psychiatry, 1991
- ECDEU Assessment ManualPublished by American Psychological Association (APA) ,1976
- A RATING SCALE FOR DEPRESSIONJournal of Neurology, Neurosurgery & Psychiatry, 1960
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958